US5939272A
(en)
*
|
1989-01-10 |
1999-08-17 |
Biosite Diagnostics Incorporated |
Non-competitive threshold ligand-receptor assays
|
CA2128320A1
(en)
*
|
1992-01-22 |
1993-08-05 |
Shanfun Ching |
Calibration reagents for semi-quantitative binding assays and devices
|
US6174686B1
(en)
*
|
1995-04-18 |
2001-01-16 |
Biosite Diagnostics, Inc. |
Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
|
US6991907B1
(en)
*
|
1995-04-18 |
2006-01-31 |
Biosite, Inc. |
Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
|
US6627404B1
(en)
*
|
1995-04-18 |
2003-09-30 |
Biosite, Inc. |
Methods for improving the recovery of troponin I and T in membranes, filters and vessels
|
CA2279675A1
(en)
*
|
1995-12-15 |
1997-06-16 |
Enzo Therapeutics, Inc. |
Property effecting and/or property exhibiting constructs for localizing a nucleic acid construct within a cell for therapeutic and diagnostic uses
|
AU7571998A
(en)
*
|
1997-05-14 |
1998-12-08 |
Biosite Diagnostics Incorporated |
Rapid evaluation of the ratio of biological molecules
|
JP2001526546A
(ja)
*
|
1997-06-11 |
2001-12-18 |
アボツト・ラボラトリーズ |
肺の疾患の検出に有用な試薬および方法
|
DE19744531A1
(de)
*
|
1997-10-09 |
1999-05-27 |
Klaus Dr Rer Nat Bosslet |
Bindemoleküle gegen Rezeptor-Ligand-Komplexe
|
US6830731B1
(en)
*
|
1998-01-05 |
2004-12-14 |
Biosite, Inc. |
Immunoassay fluorometer
|
US6392894B1
(en)
|
1998-01-05 |
2002-05-21 |
Biosite Incorporated |
Media carrier for an assay device
|
EP1212465A2
(en)
*
|
1999-09-15 |
2002-06-12 |
Miraibio Inc. |
Method for processing biological samples
|
EP1230552B1
(en)
|
1999-11-16 |
2006-01-11 |
Genentech, Inc. |
Elisa for vegf
|
US6984494B2
(en)
*
|
2000-08-15 |
2006-01-10 |
Genentech, Inc. |
Analytical method
|
AU2002231736A1
(en)
|
2000-12-22 |
2002-07-08 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Use of repulsive guidance molecule (rgm) and its modulators
|
US6770434B2
(en)
|
2000-12-29 |
2004-08-03 |
The Provost, Fellows And Scholars Of The College Of The Holy & Undivided Trinity Of Queen Elizabeth Near Dublin |
Biological assay method
|
US20040203083A1
(en)
*
|
2001-04-13 |
2004-10-14 |
Biosite, Inc. |
Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
|
US7524635B2
(en)
*
|
2003-04-17 |
2009-04-28 |
Biosite Incorporated |
Methods and compositions for measuring natriuretic peptides and uses thereof
|
US20030219734A1
(en)
*
|
2001-04-13 |
2003-11-27 |
Biosite Incorporated |
Polypeptides related to natriuretic peptides and methods of their identification and use
|
US20030199000A1
(en)
*
|
2001-08-20 |
2003-10-23 |
Valkirs Gunars E. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
WO2003016910A1
(en)
*
|
2001-08-20 |
2003-02-27 |
Biosite, Inc. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
US20040121350A1
(en)
*
|
2002-12-24 |
2004-06-24 |
Biosite Incorporated |
System and method for identifying a panel of indicators
|
US20040126767A1
(en)
*
|
2002-12-27 |
2004-07-01 |
Biosite Incorporated |
Method and system for disease detection using marker combinations
|
US7632647B2
(en)
*
|
2001-04-13 |
2009-12-15 |
Biosite Incorporated |
Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
|
US7713705B2
(en)
*
|
2002-12-24 |
2010-05-11 |
Biosite, Inc. |
Markers for differential diagnosis and methods of use thereof
|
US20040253637A1
(en)
*
|
2001-04-13 |
2004-12-16 |
Biosite Incorporated |
Markers for differential diagnosis and methods of use thereof
|
DE60233301D1
(de)
*
|
2001-05-04 |
2009-09-24 |
Biosite Inc |
Diagnostische marker für akute herzerkrankungen und verfahren des gebrauchs
|
US20040219509A1
(en)
*
|
2001-08-20 |
2004-11-04 |
Biosite, Inc. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
WO2003022028A2
(en)
*
|
2001-09-10 |
2003-03-20 |
Meso Scale Technologies, Llc |
Methods, reagents, kits and apparatus for protein function analysis
|
CA2513287A1
(en)
*
|
2002-01-14 |
2003-07-17 |
William Herman |
Multispecific binding molecules
|
US20030153011A1
(en)
*
|
2002-02-08 |
2003-08-14 |
Bell Michael L. |
Methods and reagents for conducting multiplexed assays of multiple analytes
|
US7459127B2
(en)
|
2002-02-26 |
2008-12-02 |
Siemens Healthcare Diagnostics Inc. |
Method and apparatus for precise transfer and manipulation of fluids by centrifugal and/or capillary forces
|
US7094354B2
(en)
|
2002-12-19 |
2006-08-22 |
Bayer Healthcare Llc |
Method and apparatus for separation of particles in a microfluidic device
|
US7125711B2
(en)
|
2002-12-19 |
2006-10-24 |
Bayer Healthcare Llc |
Method and apparatus for splitting of specimens into multiple channels of a microfluidic device
|
CA2522709A1
(en)
|
2003-04-17 |
2004-11-04 |
Ciphergen Biosystems, Inc. |
Polypeptides related to natriuretic peptides and methods of their identification and use
|
US7435381B2
(en)
|
2003-05-29 |
2008-10-14 |
Siemens Healthcare Diagnostics Inc. |
Packaging of microfluidic devices
|
US7347617B2
(en)
|
2003-08-19 |
2008-03-25 |
Siemens Healthcare Diagnostics Inc. |
Mixing in microfluidic devices
|
US20050164238A1
(en)
*
|
2003-09-29 |
2005-07-28 |
Biosite, Inc. |
Methods and compositions for the diagnosis of sepsis
|
US8030092B2
(en)
*
|
2003-11-07 |
2011-10-04 |
Princeton Biochemicals, Inc. |
Controlled electrophoresis method
|
US20060105419A1
(en)
*
|
2004-08-16 |
2006-05-18 |
Biosite, Inc. |
Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions
|
WO2006031583A2
(en)
*
|
2004-09-09 |
2006-03-23 |
Biosite Incorporated |
Methods and compositions for measuring canine bnp and uses thereof
|
US20080050832A1
(en)
*
|
2004-12-23 |
2008-02-28 |
Buechler Kenneth F |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
WO2006078813A2
(en)
*
|
2005-01-21 |
2006-07-27 |
Biosite Incorporated |
Arginine analogs, and methods for their synthesis and use
|
US7396689B2
(en)
*
|
2005-02-04 |
2008-07-08 |
Decision Biomarkers Incorporated |
Method of adjusting the working range of a multi-analyte assay
|
EP1888765A4
(en)
*
|
2005-06-09 |
2008-11-05 |
Biosite Inc |
METHOD AND COMPOSITIONS FOR DIAGNOSIS OF VENOUS THROMBOEMBOLIC ILLNESSES
|
EP1929295A4
(en)
*
|
2005-08-30 |
2010-03-17 |
Biosite Inc |
USE OF SOLUBLE FLT-1 AND ITS FRAGMENTS IN CARDIOVASCULAR CONDITIONS
|
CN101277974A
(zh)
*
|
2005-09-30 |
2008-10-01 |
阿伯特有限及两合公司 |
排斥性引导分子(rgm)蛋白质家族的蛋白质的结合结构域及其功能性片段和它们的用途
|
EP1808696B1
(de)
|
2006-01-14 |
2009-03-11 |
Roche Diagnostics GmbH |
Immunologisches Testelement mit verbesserter Kontrollzone
|
EP2005168A4
(en)
*
|
2006-03-09 |
2009-05-20 |
Biosite Inc |
METHODS AND COMPOSITIONS FOR DIAGNOSING DISEASES OF AORTA
|
US20080118924A1
(en)
*
|
2006-05-26 |
2008-05-22 |
Buechler Kenneth F |
Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases
|
GB0611116D0
(en)
|
2006-06-06 |
2006-07-19 |
Oxford Genome Sciences Uk Ltd |
Proteins
|
CA2687997A1
(en)
|
2006-06-07 |
2007-12-13 |
Otago Innovation Limited |
Diagnostic methods and markers
|
CN101495868A
(zh)
*
|
2006-07-28 |
2009-07-29 |
博适公司 |
利用磁性颗粒进行受体结合试验的装置和方法
|
CA2662629C
(en)
|
2006-09-07 |
2019-08-13 |
University Of Otago |
Bnp signal peptide fragments for acute cardiac disorders
|
US7842472B2
(en)
*
|
2006-11-14 |
2010-11-30 |
Alere International |
Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
|
WO2008061149A2
(en)
*
|
2006-11-14 |
2008-05-22 |
Biosite Incorporated |
Methods and compositions for diagnosis and prognosis of renal artery stenosis
|
JP5553615B2
(ja)
*
|
2007-03-01 |
2014-07-16 |
アボット・ラボラトリーズ |
プロゾーン現象の低減を示すイムノアッセイ
|
CN101021526B
(zh)
|
2007-03-16 |
2012-01-25 |
艾博生物医药(杭州)有限公司 |
一种直观显示检测结果的装置和方法
|
US8221995B2
(en)
*
|
2007-03-23 |
2012-07-17 |
Seok-Won Lee |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
US20090004755A1
(en)
*
|
2007-03-23 |
2009-01-01 |
Biosite, Incorporated |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
FI20075251A0
(fi)
*
|
2007-04-13 |
2007-04-13 |
Hytest Oy |
Immunomääritys epästabiilien antigeenien määrittämiseksi
|
EP2033971A1
(de)
*
|
2007-09-06 |
2009-03-11 |
Abbott GmbH & Co. KG |
Bone Morphogenetic Protein (BMP)-bindende Domänen von Proteinen der Repulsive Guidance Molecule (RGM) Proteinfamilie und funktionale Fragmente davon sowie deren Verwendung
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
US9630985B2
(en)
*
|
2008-03-12 |
2017-04-25 |
Otago Innovation Limited |
Biomarkers
|
US8507209B2
(en)
|
2008-03-12 |
2013-08-13 |
Otago Innovation Limited |
Biomarkers
|
WO2009126336A1
(en)
*
|
2008-04-11 |
2009-10-15 |
Becton, Dickinson And Company |
Methods of controlling the sensitivity and dynamic range of a homogeneous assay
|
FI20085579A0
(fi)
*
|
2008-06-12 |
2008-06-12 |
Valtion Teknillinen |
Kannabiskäytön toteaminen
|
EP2330128B1
(en)
|
2008-08-27 |
2015-12-23 |
LSI Medience Corporation |
Modified anti-heparin/pf4 complex antibody and hit antibody standard
|
JP2012501456A
(ja)
|
2008-08-28 |
2012-01-19 |
アスチュート メディカル,インコーポレイテッド |
腎損傷および腎不全の診断および予後のための方法および組成物
|
EP2324354B1
(en)
|
2008-08-29 |
2014-07-16 |
Astute Medical, Inc. |
Methods for prognosis of acute renal failure
|
DE102008049601A1
(de)
|
2008-09-30 |
2010-04-01 |
Siemens Healthcare Diagnostics Products Gmbh |
Antikörper zur Bestimmung des Prothrombin-Fragments F2/F1+2 in einem homogenen Immunoassay
|
NZ592365A
(en)
|
2008-10-21 |
2014-08-29 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
NZ592358A
(en)
|
2008-10-21 |
2013-05-31 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure using tissue inhibitor of metalloproteinase 2 (timp-2)
|
CN104330574B
(zh)
|
2008-11-10 |
2017-04-12 |
阿斯图特医药公司 |
用于诊断和预后肾损伤和肾衰竭的方法和组合物
|
MX2011005379A
(es)
|
2008-11-22 |
2011-06-09 |
Astute Medical Inc |
Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
|
WO2010065944A1
(en)
*
|
2008-12-05 |
2010-06-10 |
Serametrix |
Autoantibody detection systems and methods
|
AU2010210537B2
(en)
|
2009-02-06 |
2015-06-18 |
Astute Medical, Inc. |
Diagnosis and prognosis of renal injury and renal failure
|
US20120053072A1
(en)
|
2009-02-06 |
2012-03-01 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
US8167871B2
(en)
*
|
2009-02-25 |
2012-05-01 |
The Invention Science Fund I, Llc |
Device for actively removing a target cell from blood or lymph of a vertebrate subject
|
US8317737B2
(en)
*
|
2009-02-25 |
2012-11-27 |
The Invention Science Fund I, Llc |
Device for actively removing a target component from blood or lymph of a vertebrate subject
|
CA2767616A1
(en)
|
2009-07-09 |
2011-01-13 |
The Scripps Research Institute |
Gene expression profiles associated with chronic allograft nephropathy
|
BRPI1005176B1
(pt)
*
|
2009-07-21 |
2021-06-08 |
Sekisui Medical Co., Ltd |
ensaio de insulina e reagente de ensaio de insulina
|
NZ598035A
(en)
|
2009-08-07 |
2014-06-27 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
NZ598034A
(en)
|
2009-08-07 |
2014-06-27 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
AU2010286559B2
(en)
|
2009-08-28 |
2015-01-22 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
WO2011035097A1
(en)
|
2009-09-18 |
2011-03-24 |
Astute Medical, Inc. |
Methods and composition for diagnosis and prognosis of renal injury and renal failure
|
EP2480882A4
(en)
|
2009-09-21 |
2013-07-10 |
Astute Medical Inc |
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL LESIONS AND FAILURES
|
US10324093B2
(en)
|
2009-11-07 |
2019-06-18 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP3153863B1
(en)
|
2009-11-07 |
2020-04-01 |
Astute Medical, Inc. |
Methods and uses for evaluation of acute renal failure/acute renal injury
|
PL2510001T3
(pl)
*
|
2009-12-08 |
2016-06-30 |
Abbvie Deutschland |
Monoklonalne przeciwciało przeciwko białku RGM A do zastosowania w leczeniu zwyrodnienia warstwy włókien nerwowych siatkówki (RNFL)
|
ES2592386T3
(es)
|
2009-12-20 |
2016-11-29 |
Astute Medical, Inc. |
Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal
|
CA2789147A1
(en)
|
2010-02-05 |
2011-08-11 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
WO2011097539A1
(en)
|
2010-02-05 |
2011-08-11 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
JP5998055B2
(ja)
|
2010-02-05 |
2016-09-28 |
アスチュート メディカル,インコーポレイテッド |
腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
|
WO2011162819A1
(en)
|
2010-06-23 |
2011-12-29 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP2539712A4
(en)
|
2010-02-26 |
2013-09-18 |
Astute Medical Inc |
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
|
WO2011129382A1
(en)
|
2010-04-16 |
2011-10-20 |
Abbott Japan Co. Ltd. |
Methods and reagents for diagnosing rheumatoid arthritis
|
CA2804297A1
(en)
|
2010-06-23 |
2011-12-29 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
CA2803500A1
(en)
|
2010-06-23 |
2011-12-29 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
CA2805794A1
(en)
|
2010-07-19 |
2012-01-26 |
Otago Innovation Limited |
Signal biomarkers
|
US8956859B1
(en)
|
2010-08-13 |
2015-02-17 |
Aviex Technologies Llc |
Compositions and methods for determining successful immunization by one or more vaccines
|
US10557856B2
(en)
|
2010-09-24 |
2020-02-11 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Biomarkers of renal injury
|
EP2619231B1
(en)
|
2010-09-24 |
2016-12-21 |
Astute Medical, Inc. |
Methods for the evaluation of renal injury using hyaluronic acid
|
US20130316370A1
(en)
|
2010-10-07 |
2013-11-28 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP2646822B1
(en)
|
2010-11-29 |
2017-11-01 |
Alere San Diego, Inc. |
Methods for diagnosis and risk prediction in heart failure
|
EP3828544A1
(en)
|
2011-01-08 |
2021-06-02 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP3761034A3
(en)
|
2011-01-26 |
2021-02-17 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Urine biomarkers for prediction of recovery after acute kidney injury: proteomics
|
US20130330752A1
(en)
|
2011-01-29 |
2013-12-12 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP2748605B1
(en)
|
2011-08-26 |
2018-12-05 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
CA2856399A1
(en)
|
2011-11-22 |
2013-05-30 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP3540440B1
(en)
|
2011-12-08 |
2022-09-28 |
Astute Medical, Inc. |
Methods and uses for evaluating renal injury and renal status
|
WO2013090633A2
(en)
|
2011-12-14 |
2013-06-20 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
AU2012352168C1
(en)
|
2011-12-14 |
2018-01-25 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
IL305223A
(en)
|
2012-01-27 |
2023-10-01 |
Abbvie Inc |
The composition and method for the diagnosis and treatment of diseases related to the degeneration of nerve cells
|
WO2013130594A1
(en)
|
2012-02-27 |
2013-09-06 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
RU2014141059A
(ru)
|
2012-03-13 |
2016-04-27 |
Эббви Инк. |
Способ отбора или идентификации субъекта для терапии антагонистом v1b
|
ES2661516T3
(es)
|
2012-03-20 |
2018-04-02 |
Otago Innovation Limited |
Biomarcadores
|
EP3699591A1
(en)
|
2012-04-02 |
2020-08-26 |
Astute Medical, Inc. |
Methods for diagnosis and prognosis of sepsis
|
US9733261B2
(en)
|
2012-04-24 |
2017-08-15 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of stroke or other cerebral injury
|
US9804161B1
(en)
*
|
2012-05-14 |
2017-10-31 |
Lawrence Livermore National Security, Llc |
Detector and related, devices, methods and systems
|
EP3572809A1
(en)
|
2012-07-23 |
2019-11-27 |
Astute Medical, Inc. |
Methods for diagnosis of sepsis
|
EP2882767B1
(en)
|
2012-08-11 |
2023-07-12 |
Astute Medical, Inc. |
Evaluating renal injury using hyaluronic acid
|
EP2946211B1
(en)
|
2013-01-17 |
2018-02-28 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
US9694069B2
(en)
|
2013-03-14 |
2017-07-04 |
Alere San Diego, Inc. |
6-acetylmorphine analogs, and methods for their synthesis and use
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
CN105556305A
(zh)
|
2013-06-05 |
2016-05-04 |
阿斯图特医药公司 |
用于肾损伤和肾衰竭的诊断及预后的方法和组合物
|
JP6581572B2
(ja)
|
2013-06-07 |
2019-09-25 |
デューク ユニバーシティ |
補体因子h阻害薬
|
EP3617234A1
(en)
|
2013-08-07 |
2020-03-04 |
Astute Medical, Inc. |
Assays for timp2 having improved performance in biological samples
|
IL285832B2
(en)
|
2013-08-23 |
2024-01-01 |
Reata Pharmaceuticals Inc |
Methods for the treatment and prevention of impaired functioning of the endothelium using brodoxolone methyl or its analogs
|
WO2015031626A1
(en)
|
2013-08-28 |
2015-03-05 |
Abbvie Inc. |
Soluble cmet assay
|
NL2011406C2
(en)
|
2013-09-06 |
2015-03-10 |
Bionovion Holding B V |
Method for obtaining april-binding peptides, process for producing the peptides, april-binding peptides obtainable with said method/process and use of the april-binding peptides.
|
CN105556308B
(zh)
|
2013-09-20 |
2018-05-29 |
阿斯图特医药公司 |
用于阑尾炎的诊断和预后及腹痛病因的区分的方法和组合物
|
KR102404285B1
(ko)
|
2013-11-06 |
2022-05-31 |
아스튜트 메디컬 인코포레이티드 |
생물학적 샘플에서 개선된 성능을 갖는 igfbp7에 대한 분석
|
EP3077819A4
(en)
|
2013-12-03 |
2017-06-28 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
JP2017506910A
(ja)
|
2013-12-30 |
2017-03-16 |
ザ ヘンリー エム. ジャクソン ファウンデーション フォー ザ アドヴァンスメント オブ ミリタリー メディシン インコーポレイテッド |
前立腺癌に関連したゲノム再編成及び該ゲノム再編成の使用方法
|
EP3825416A3
(en)
|
2014-05-22 |
2021-09-15 |
The Scripps Research Institute |
Gene expression profiles associated with sub-clinical kidney transplant rejection
|
US11104951B2
(en)
|
2014-05-22 |
2021-08-31 |
The Scripps Research Institute |
Molecular signatures for distinguishing liver transplant rejections or injuries
|
US10443100B2
(en)
|
2014-05-22 |
2019-10-15 |
The Scripps Research Institute |
Gene expression profiles associated with sub-clinical kidney transplant rejection
|
EP3146077A4
(en)
|
2014-05-22 |
2018-05-02 |
The Scripps Research Institute |
Tissue molecular signatures of kidney transplant rejections
|
CA2949959A1
(en)
|
2014-05-22 |
2015-11-26 |
Northwestern University |
Gene expression profiles associated with sub-clinical kidney transplant rejection
|
EP3968022A1
(en)
|
2014-10-20 |
2022-03-16 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP3233106B1
(en)
|
2014-12-18 |
2023-02-01 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
WO2016164854A1
(en)
|
2015-04-09 |
2016-10-13 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP3294416A4
(en)
|
2015-05-12 |
2018-11-21 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP3308166A4
(en)
|
2015-06-11 |
2019-05-15 |
Astute Medical, Inc. |
METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
|
WO2016205740A1
(en)
|
2015-06-17 |
2016-12-22 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of appendicitis and differentiation of causes of abdominal pain
|
JP2018523469A
(ja)
|
2015-07-10 |
2018-08-23 |
ウエストバージニア ユニバーシティWest Virginia University |
脳卒中および脳卒中重篤度のマーカー
|
EP3458439B1
(en)
|
2016-05-18 |
2021-12-08 |
Alere San Diego, Inc. |
2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine analogs and methods for their synthesis and use
|
CA3026502A1
(en)
|
2016-06-06 |
2017-12-14 |
Astute Medical, Inc. |
Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
|
NL2017267B1
(en)
|
2016-07-29 |
2018-02-01 |
Aduro Biotech Holdings Europe B V |
Anti-pd-1 antibodies
|
US20180106800A1
(en)
|
2016-10-03 |
2018-04-19 |
Abbott Laboratories |
Methods of assessing uch-l1 status in patient samples
|
EP3522893A4
(en)
|
2016-10-04 |
2020-08-26 |
University Of Maryland, Baltimore |
METHODS OF TREATMENT OF SEPTICEMIA USING LIPID A-BASED THERAPEUTIC AGENTS (ASLA) ANTISEPSY
|
MX2019005401A
(es)
|
2016-11-08 |
2019-08-05 |
Reata Pharmaceuticals Inc |
Metodos para tratar el sindrome de alport con bardoxolona metilo o analogos de la misma.
|
WO2018132702A1
(en)
|
2017-01-12 |
2018-07-19 |
Astute Medical, Inc. |
Methods and compositions for evaluation and treatment of renal injury and renal failure based on c-c motif chemokine ligand 14 measurement
|
WO2018164580A1
(en)
|
2017-03-09 |
2018-09-13 |
Rijksuniversiteit Groningen |
Biomarkers for cellular senescence
|
JP7346300B2
(ja)
|
2017-03-23 |
2023-09-19 |
アボット・ラボラトリーズ |
早期バイオマーカーであるユビキチンカルボキシ末端ヒドロラーゼl1を使用する、ヒト対象における外傷性脳損傷の程度の診断及び決定の一助となるための方法
|
CA3053409A1
(en)
|
2017-04-15 |
2018-10-18 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
|
JP7080899B2
(ja)
|
2017-04-28 |
2022-06-06 |
アボット・ラボラトリーズ |
同じヒト対象に由来する少なくとも2つの試料に対して早期バイオマーカーを使用する、外傷性脳損傷の超急性の診断及び決定の一助となるための方法
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
JP2020519904A
(ja)
|
2017-05-07 |
2020-07-02 |
アスチュート メディカル,インコーポレイテッド |
腎代替療法の管理におけるインスリン様増殖因子結合タンパク質7および組織メタロプロテアーゼ阻害物質2の使用
|
EP3631465A1
(en)
|
2017-05-25 |
2020-04-08 |
Abbott Laboratories |
Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
|
WO2018222783A1
(en)
|
2017-05-30 |
2018-12-06 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin i and early biomarkers
|
JP7454945B2
(ja)
|
2017-07-03 |
2024-03-25 |
アボット・ラボラトリーズ |
血液中のユビキチンカルボキシ末端ヒドロラーゼl1レベルを測定するための、改善された方法
|
BR112020010085A2
(pt)
|
2017-12-09 |
2020-10-13 |
Abbott Laboratories |
métodos para auxiliar no diagnóstico e avaliar uma lesão cerebral traumática em um indivíduo humano usando uma combinação de gfap e uch-l1
|
BR112019028254A2
(pt)
|
2017-12-09 |
2020-07-14 |
Abbott Laboratories |
métodos para ajudar no diagnóstico e avaliação de um paciente que sofreu uma lesão ortopédica e que sofreu ou pode ter sofrido uma lesão na cabeça, tal como uma lesão cerebral traumática (lct) leve, usando a proteína ácida fibrilar glial (gfap) e/ou a hidrolase carbóxi-terminal da ubiquitina l1 (uch-l1)
|
US11891439B2
(en)
|
2017-12-28 |
2024-02-06 |
Astute Medical, Inc. |
Antibodies and assays for CCL14
|
WO2019133717A1
(en)
|
2017-12-29 |
2019-07-04 |
Abbott Laboratories |
Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury
|
EP3788377A1
(en)
|
2018-05-04 |
2021-03-10 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|
EP3846797A4
(en)
|
2018-09-04 |
2022-06-08 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
USE OF DELTA-TOCOTRIENOL FOR THE TREATMENT OF CANCER
|
WO2020140071A1
(en)
|
2018-12-28 |
2020-07-02 |
Abbott Laboratories |
Direct detection of single molecules on microparticles
|
WO2020144535A1
(en)
|
2019-01-08 |
2020-07-16 |
Aduro Biotech Holdings, Europe B.V. |
Methods and compositions for treatment of multiple myeloma
|
US11079395B2
(en)
|
2019-03-01 |
2021-08-03 |
Abbott Laboratories |
Methods for predicting major adverse cardiovascular events in subjects with coronary artery disease
|
EP4136459A1
(en)
|
2020-04-13 |
2023-02-22 |
Abbott Laboratories |
Methods, complexes and kits for detecting or determining an amount of a ss-coronavirus antibody in a sample
|
US20230255982A1
(en)
|
2020-05-09 |
2023-08-17 |
Reata Pharmaceuticals Holdings, LLC |
Methods of treating covid-19 using bardoxolone methyl or analogs thereof
|
EP4158352A1
(en)
|
2020-06-01 |
2023-04-05 |
Loop Diagnostics, S.L. |
Method and kit for the early detection of sepsis
|
WO2022029494A1
(en)
|
2020-08-04 |
2022-02-10 |
Abbott Rapid Diagnostics International Unlimited Company |
Assays for detecting sars-cov-2
|
CA3188349A1
(en)
|
2020-08-04 |
2022-02-10 |
A. Scott Muerhoff |
Improved methods and kits for detecting sars-cov-2 protein in a sample
|
CN112051403A
(zh)
*
|
2020-08-27 |
2020-12-08 |
武汉生之源生物科技股份有限公司 |
C反应蛋白化学发光免疫检测试剂盒及其制备方法和应用
|
WO2022119841A1
(en)
|
2020-12-01 |
2022-06-09 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
AU2021397631A1
(en)
|
2020-12-11 |
2023-07-20 |
Reata Pharmaceuticals Holdings, LLC |
Synthetic triterpenoids for use in therapy
|
WO2022147147A1
(en)
|
2020-12-30 |
2022-07-07 |
Abbott Laboratories |
Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
|
BR112023024169A2
(pt)
|
2021-05-18 |
2024-02-06 |
Abbott Lab |
Métodos para avaliar lesão cerebral em um indivíduo pediátrico
|
CA3222291A1
(en)
|
2021-06-14 |
2022-12-22 |
Jaime MARINO |
Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
|
WO2023028186A1
(en)
|
2021-08-27 |
2023-03-02 |
Abbott Laboratories |
Methods for detecting immunoglobulin g, subclass 4 (igg4) in a biological sample
|
WO2023034777A1
(en)
|
2021-08-31 |
2023-03-09 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
WO2023056268A1
(en)
|
2021-09-30 |
2023-04-06 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
WO2023114978A1
(en)
|
2021-12-17 |
2023-06-22 |
Abbott Laboratories |
Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
|
WO2023129942A1
(en)
|
2021-12-28 |
2023-07-06 |
Abbott Laboratories |
Use of biomarkers to determine sub-acute traumatic brain injury (tbi) in a subject having received a head computerized tomography (ct) scan that is negative for a tbi or no head ct scan
|
WO2023144206A1
(en)
|
2022-01-27 |
2023-08-03 |
Sanofi Pasteur |
Modified vero cells and methods of using the same for virus production
|
WO2023150652A1
(en)
|
2022-02-04 |
2023-08-10 |
Abbott Laboratories |
Lateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample
|
WO2023212293A1
(en)
|
2022-04-29 |
2023-11-02 |
Broadwing Bio Llc |
Complement factor h related 4-specific antibodies and uses thereof
|
WO2023212294A1
(en)
|
2022-04-29 |
2023-11-02 |
Broadwing Bio Llc |
Angiopoietin-related protein 7-specific antibodies and uses thereof
|
WO2023212298A1
(en)
|
2022-04-29 |
2023-11-02 |
Broadwing Bio Llc |
Bispecific antibodies and methods of treating ocular disease
|
WO2024059708A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Biomarkers and methods for differentiating between mild and supermild traumatic brain injury
|
WO2024059692A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|